{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Africa", "Occult hepatitis B", "Occult hepatitis C", "Prevalence"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36395668", "DateCompleted": {"Year": "2022", "Month": "12", "Day": "06"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "06"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "11", "Day": "12"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jiph.2022.11.008", "S1876-0341(22)00303-3"], "Journal": {"ISSN": "1876-035X", "JournalIssue": {"Volume": "15", "Issue": "12", "PubDate": {"Year": "2022", "Month": "Dec"}}, "Title": "Journal of infection and public health", "ISOAbbreviation": "J Infect Public Health"}, "ArticleTitle": "Epidemiology of occult hepatitis B and C in Africa: A systematic review and meta-analysis.", "Pagination": {"StartPage": "1436", "EndPage": "1445", "MedlinePgn": "1436-1445"}, "Abstract": {"AbstractText": ["Occult hepatitis B (OBI) and C (OCI) infections lead to hepatic crises including cases of liver cirrhosis and even hepatocellular carcinoma (HCC). OBI and OCI also pose a significant problem of their transmissibility. This study aimed to assess the overall prevalence of OBI and OCI in the African continent, a region highly endemic for classical hepatitis B and C viruses.", "For this systematic review and meta-analysis, we searched: PubMed, Web of Science, African Journal Online and African Index Medicus for published studies on the prevalence of OBI and OCI in Africa. Study selection and data extraction were performed by at least two independent investigators. Heterogeneity (I\u00b2) was assessed using the \u03c7\u00b2 test on the Cochran Q statistic and H parameters. Sources of heterogeneity were explored by subgroup analyses. This study was registered in PROSPERO, with reference number CRD42021252772.", "We obtained 157 prevalence data for this meta-analysis, from 134 studies for OBI prevalence; 23 studies on OCI prevalence, and a single study on the OBI case fatality rate. The overall estimate for the prevalence of OBI was 14.8% [95% CI =\u00a012.2-17.7] among 18579 participants. The prevalence of seronegative OBI and seropositive OBI was 7.4% [95% CI =\u00a03.8-11.8] and 20.0% [95% CI =\u00a015.3-25.1] respectively. The overall estimate for the prevalence of OCI was 10.7% [95% CI =\u00a06.6-15.4] among 2865 participants. The pooled prevalence of seronegative OCI was estimated at 10.7% [95%CI =\u00a04.8-18.3] and that of seropositive OCI at 14.4% [95%CI =\u00a05.2-22.1]. In Sub-group analysis, patients with malignancies, chronic hepatitis C, and hemodialysis had a higher OCI prevalence. While those with malignancies, liver disorders, and HIV positive registered highest OBI prevalence.", "This review shows a high prevalence of OBI and OCI in Africa, with variable prevalence between countries and population groups."], "CopyrightInformation": "Copyright \u00a9 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon; Molecular Biology Laboratory, Chantal Biya International Reference Centre for AIDS Research (CIRCB), Yaounde, Cameroon."}], "LastName": "Ondigui", "ForeName": "Juliette Laure Ndzie", "Initials": "JLN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon. Electronic address: sebastien.kenmoe@ubuea.cm."}], "LastName": "Kenmoe", "ForeName": "Sebastien", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Epidemiological Surveillance, Evaluation and Research Unit, National AIDS Control Committee, Douala, Cameroon."}], "LastName": "Kengne-Nd\u00e9", "ForeName": "Cyprien", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Research Centre, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon."}], "LastName": "Ebogo-Belobo", "ForeName": "Jean Thierry", "Initials": "JT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Food, Food Security and Nutrition Research, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon."}], "LastName": "Takuissu", "ForeName": "Guy Roussel", "Initials": "GR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Kenfack-Momo", "ForeName": "Raoul", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Mbaga", "ForeName": "Donatien Serge", "Initials": "DS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Scientific Direction, Centre Pasteur of Cameroon, Yaounde, Cameroon."}], "LastName": "Tchatchouang", "ForeName": "Serges", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Kenfack-Zanguim", "ForeName": "Josiane", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Animal Biology, University of Dschang, Dschang, Cameroon."}], "LastName": "Fogang", "ForeName": "Robertine Lontuo", "Initials": "RL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, University of Buea, Buea, Cameroon."}], "LastName": "Menkem", "ForeName": "Elisabeth Zeuko'o", "Initials": "EZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Research Centre, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon."}], "LastName": "Kame-Ngasse", "ForeName": "Ginette Irma", "Initials": "GI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Magoudjou-Pekam", "ForeName": "Jeannette Nina", "Initials": "JN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Bowo-Ngandji", "ForeName": "Arnol", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Biology Laboratory, Chantal Biya International Reference Centre for AIDS Research (CIRCB), Yaounde, Cameroon."}], "LastName": "Goumkwa", "ForeName": "Nad\u00e8ge Mafopa", "Initials": "NM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon."}], "LastName": "Esemu", "ForeName": "Seraphine Nkie", "Initials": "SN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon."}], "LastName": "Ndip", "ForeName": "Lucy", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Essama", "ForeName": "Sara Honorine Riwom", "Initials": "SHR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Biology Laboratory, Chantal Biya International Reference Centre for AIDS Research (CIRCB), Yaounde, Cameroon."}], "LastName": "Torimiro", "ForeName": "Judith", "Initials": "J"}], "PublicationTypeList": ["Meta-Analysis", "Systematic Review", "Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Infect Public Health", "NlmUniqueID": "101487384", "ISSNLinking": "1876-0341"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Carcinoma, Hepatocellular"}, {"QualifierName": [], "DescriptorName": "Liver Neoplasms"}, {"QualifierName": ["epidemiology"], "DescriptorName": "Hepatitis B"}, {"QualifierName": [], "DescriptorName": "Liver Cirrhosis"}, {"QualifierName": ["epidemiology"], "DescriptorName": "Africa"}], "CoiStatement": "Competing interests None."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Thiers V, Nakajima E, Kremsdorf D, Mack D, Schellekens H, Driss F, et al. Transmission of Hepatitis B from Hepatitis-B-seronegative subjects. Lancet. 1988;332(8623):1273\u20136.", "ArticleIdList": ["2904005"]}, {"Citation": "Vallet-Pichard A, Pol S. L\u2019h\u00e9patite B occulte. Virologie. 2008;12(2):87\u201394.", "ArticleIdList": ["36131428"]}, {"Citation": "Esmail MA, Mahdi WK, Khairy RM, Abdalla NH. Genotyping of occult hepatitis B virus infection in Egyptian hemodialysis patients without hepatitis C virus infection. J Infect Public Health. 2016;9(4):452\u20137.", "ArticleIdList": ["26778093"]}, {"Citation": "Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus in-fection. J Hepatol. 2007;46(1):160\u201370.", "ArticleIdList": ["17112622"]}, {"Citation": "Castillo I, Rodr\u00edguez-I\u00f1igo E, Bartolom\u00e9 J, de Lucas S, Ort\u00edz-Movilla N, L\u00f3pez-Alcorocho JM, et al. Hepatitis C virus replicates in peripheral blood mono-nuclear cells of patients with occult hepatitis C virus infection. Gut. 2005;54(5):682\u20135.", "ArticleIdList": ["PMC1774478", "15831916"]}, {"Citation": "Chevaliez S. Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection 9. JOHN LIBBEY EUROTEXT; 2005.", "ArticleIdList": ["34679301"]}, {"Citation": "Austria A, Wu GY. Occult Hepatitis C Virus Infection: A Review. J Clin Transl Hepatol. 2018;6(2):155\u201360.", "ArticleIdList": ["PMC6018308", "29951360"]}, {"Citation": "Rezaee-Zavareh MS, Hadi R, Karimi-Sari H, Hossein Khosravi M, Ajudani R, Dolatimehr F, et al. Occult HCV infection: the current state of knowledge. Iran Red Crescent Med J. 2015;17(11):e34181.", "ArticleIdList": ["PMC4698335", "26734487"]}, {"Citation": "Huang X, Hollinger FB. Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review. J Viral Hepat. 2014;21(3):153\u201362.", "ArticleIdList": ["24438677"]}, {"Citation": "Carre\u00f1o V, Bartolom\u00e9 J, Castillo I, Quiroga JA. New perspectives in occult hepatitis C virus infection. World J Gastroenterol. 2012;18(23):2887\u201394.", "ArticleIdList": ["PMC3380315", "22736911"]}, {"Citation": "Dolatimehr F, Khosravi MH, Rezaee-Zavareh MS, Alavian SM. Prevalence of occult HCV infection in hemodialysis and kidney-transplanted patients: a sys-tematic review. Future Virol. 2017;12(5):315\u201322."}, {"Citation": "Eltom K, Albeely A, El Hussein A, Elkhidir IM, Enan K. Occult hepatitis B virus infection in Sudan: a systematic review and meta-analysis. JGH Open. 2020;4(5):800\u20137.", "ArticleIdList": ["PMC7578306", "33102748"]}, {"Citation": "Fu S, et al. Prevalence of occult hepatitis C virus infection in patients with chronic liver disease: a systematic review and meta-analysis. Hepatol Int. 2020;14:S130."}, {"Citation": "Hedayati-Moghaddam MR, Soltanian H, Ahmadi-Ghezeldasht S. Occult hepa-titis C virus infection in the Middle East and Eastern Mediterranean countries: a systematic review and meta-analysis. World J Hepatol. 2021;13(2):242\u201360.", "ArticleIdList": ["PMC7934012", "33708353"]}, {"Citation": "Ji DZ, Pang XY, Shen DT, Liu SN, Goyal H, Xu HG. Global prevalence of occult hepatitis B: A systematic review and meta-analysis. J Viral Hepat. 2022;29(5):317\u201329.", "ArticleIdList": ["35253969"]}, {"Citation": "Kajogoo VD, Swai SS, Gurung S. Prevalence of occult hepatitis B among HIV-positive individuals in Africa: A systematic review and meta-analysis 10. SAGE Open Med. 2022:20503121211072748.", "ArticleIdList": ["PMC8808011", "35127096"]}, {"Citation": "Mbaga DS, Kenmoe S, Biko\u00ef JN, Takuissu GR, Amougou-Atsama M, Okobalemba EA, et al. Global prevalence of occult hepatitis C virus: a systematic review and meta-analysis. World J Method. 2022;12(3):179\u201390.", "ArticleIdList": ["PMC9157636", "35721241"]}, {"Citation": "Pisaturo M, Onorato L, Russo A, Chiodini P, Coppola N. An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta-analysis. J Viral Hepat. 2020;27(4):415\u201327.", "ArticleIdList": ["31834645"]}, {"Citation": "Xie WY, Sun C, He H, Deng C, Sheng Y. Estimates of the prevalence of occult HBV infection in Asia: a systematic review and meta-analysis. Infect Dis (Lond) 2022;54(12):881\u201396.", "ArticleIdList": ["36047593"]}, {"Citation": "Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6(7):e1000097.", "ArticleIdList": ["PMC2707599", "19621072"]}, {"Citation": "Manzini P, Abate ML, Valpreda C, Milanesi P, Curti F, Rizzetto M, et al. Evidence of acute primary occult hepatitis B virus infection in an Italian repeat blood donor. Transfusion. 2009;49(4):757\u201364.", "ArticleIdList": ["19171000"]}, {"Citation": "Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS, et al. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol. 2019;71(2):397\u2013408.", "ArticleIdList": ["31004683"]}, {"Citation": "Choi D, Lee G, Kim KH, Bae H. Particulate matter exacerbates the death of dopaminergic neurons in Parkinson\u2019s Disease through an inflammatory response. Int J Mol Sci. 2022;23(12)", "ArticleIdList": ["PMC9223534", "35742931"]}, {"Citation": "Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934\u20139.", "ArticleIdList": ["22742910"]}, {"Citation": "DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.", "ArticleIdList": ["3802833"]}, {"Citation": "Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101\u201329."}, {"Citation": "Veroniki AA, Jackson D, Viechtbauer W, Bender R, Bowden J, Knapp G, et al. Methods to estimate the between-study variance and its uncertainty in meta-analysis. Res Synth Methods. 2016;7(1):55\u201379.", "ArticleIdList": ["PMC4950030", "26332144"]}, {"Citation": "Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj. 1997;315(7109):629\u201334.", "ArticleIdList": ["PMC2127453", "9310563"]}, {"Citation": "Schwarzer G. meta: An R Package for Meta-Analysis. 2007;7:40\u201345."}, {"Citation": "Borenstein MH, Higgins Larry V, Julian PT, Rothstein Hannah R. Introduction to Meta-Analysis. John Wiley and Sons; 2009. p. 421."}, {"Citation": "Emad Allam M, et al. Hepatitis C virus in peripheral mononuclear cells in patients on regular hemodialysis. 2017:547\u2013552."}, {"Citation": "Mamdouh ME, Tamer M, Nayel Abd Elhamed Z. Occult Hepatitis B virus infection among Egyptian hepatitis C virus seropositive and seronegative hemodialysis patients in Sohag government. Upper Egypt. 2015:113\u2013118."}, {"Citation": "Gachara G, Magoro T, Mavhandu L, Lum E, Kimbi HK, Ndip RN, et al. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon. AIDS Res Ther. 2017;14(1):11.", "ArticleIdList": ["PMC5341455", "28270215"]}, {"Citation": "Mahmoud OAEK, Ghazal AAER, Metwally DES, Shamseya MM, Hamdallah HM. Detection of occult hepatitis B virus among chronic hepatitis C patients. Alex J Med. 2016;52(2):115\u201323."}, {"Citation": "N\u2019Dri-Yoman T, Anglaret X, Messou E, Attia A, Polneau S, Toni T, et al. Occult HBV infection in untreated HIV-infected adults in Cote d\u2019Ivoire. Antivir Ther. 2010;15(7):1029\u201334.", "ArticleIdList": ["21041918"]}, {"Citation": "Ali NK, Mohamed RR, Saleh BE, Alkady MM, Farag ES. Occult hepatitis C virus infection among haemodialysis patients. Arab J Gastroenterol. 2018;19(3):101\u20135.", "ArticleIdList": ["30245116"]}, {"Citation": "Akintule OA, Olusola BA, Odaibo GN, Olaleye DO. Occult HBV infection in Nigeria. Arch Basic Appl Med. 2018;6(1):87\u201393.", "ArticleIdList": ["PMC6022766", "29963604"]}, {"Citation": "Hannachi N, Bahri O, Ben Fredj N, Boukadida J, Triki H. Risk of vertical transmission of hepatitis B virus in Tunisia. Arch Inst Pasteur Tunis. 2010;87(1-2):17\u201324.", "ArticleIdList": ["21604457"]}, {"Citation": "Dhifallah I, Khedhiri M, Chouikha A, Kharroubi G, Hammami W, Sadraoui A, et al. Hepatitis viruses take advantage of traditional practices to increase the burden of hepatocellular carcinoma in Tunisia. Arch Virol. 2020;165(1):33\u201342.", "ArticleIdList": ["31630275"]}, {"Citation": "Fopa D, Candotti D, Tagny CT, Doux C, Mbanya D, Murphy EL, et al. Occult hepatitis B infection among blood donors from Yaound\u00e9, Cameroon. Blood Transfus. 2019;17(6):403\u20138.", "ArticleIdList": ["PMC6917532", "31846605"]}, {"Citation": "Gouas DA, Villar S, Ortiz-Cuaran S, Legros P, Ferro G, Kirk GD, et al. TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia. Carcinogenesis. 2012;33(6):1219\u201324.", "ArticleIdList": ["PMC3388490", "22759751"]}, {"Citation": "Khattab MA, Zakaria Y, Sadek E, Abd El Fatah AS, Fouad M, Khattab M, et al. Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response. Clin Exp Med. 2022", "ArticleIdList": ["PMC9939488", "35066710"]}, {"Citation": "Elgohry I, Elbanna A, Hashad D. Occult hepatitis B virus infection in a cohort of Egyptian chronic hemodialysis patients. Clin Lab. 2012;58(9-10):1057\u201361.", "ArticleIdList": ["23163124"]}, {"Citation": "Salpini R, Fokam J, Ceccarelli L, Santoro MM, Nanfack A, Sosso SM, et al. High burden of HBV-infection and atypical HBV strains among HIV-infected Cameroonians. Curr HIV Res. 2016;14(2):165\u201371.", "ArticleIdList": ["26419862"]}, {"Citation": "Elkashef KA, Emam WA, Mesbah NM, Abo-Elmatty DM, Abdel-Hamed AR. Prevalence of occult Hepatitis C virus infection in egyptian patients with lymphoma: a new vision. Diagn (Basel) 2022;12(4)", "ArticleIdList": ["PMC9029505", "35454063"]}, {"Citation": "Elmaghloub R, Elbahrawy A, El Didamony G, Hashim A, Morsy MH, Hantour O, et al. Occult hepatitis B infection in Egyptian health care workers. East Mediterr Health J. 2017;23(5):329\u201334.", "ArticleIdList": ["28730585"]}, {"Citation": "Kishk R, Atta HA, Ragheb M, Kamel M, Metwally L, Nemr N. Genotype characterization of occult hepatitis B virus strains among Egyptian chronic hepatitis C patients. East Mediterr Health J. 2014;20(2):130\u20138.", "ArticleIdList": ["24945562"]}, {"Citation": "Daef EA, Makhlouf NA, Ahmed EH, Mohamed AI, Abd El Aziz MH, El-Mokhtar MA. Serological and molecular diagnosis of occult hepatitis B virus infection in Hepatitis C chronic liver diseases. Egypt J Immunol. 2017;24(1):37\u201348.", "ArticleIdList": ["29120576"]}, {"Citation": "Mahmoud AI, Elsherbiny NM, Afifi NA, Ahmed BM, Yasin AS. Occult Hepatitis B infection among blood donors in Al Azhar university hospital, Upper Egypt: the current status after 25 years of vaccine introduction. Egypt J Immunol. 2018;25(1):45\u201356.", "ArticleIdList": ["30242997"]}, {"Citation": "Mohamed EA, Elballat MAE, El-Awdy MMK. Hepatitis C virus in peripheral mononuclear cells in patients on regular hemodialysis. Egypt J Hosp Med. 2017;67(2):547\u201352."}, {"Citation": "Taha SE, El-Hady SA, Ahmed TM, Ahmed IZ. Detection of occult HBV infection by nested PCR assay among chronic hepatitis C patients with and without hepatocellular carcinoma. Egypt J Med Hum Genet. 2013;14(4):353\u201360."}, {"Citation": "El-Shishtawy S, Sherif N, Abdallh E, Kamel L, Shemis M, Saleem AA, et al. Occult Hepatitis C virus infection in hemodialysis patients; single center study. Electron Physician. 2015;7(8):1619\u201325.", "ArticleIdList": ["PMC4725416", "26816589"]}, {"Citation": "Abdelmoemen G, Khodeir SA, Abou-Saif S, Kobtan A, Abd-Elsalam S. Prevalence of occult hepatitis C virus among hemodialysis patients in Tanta university hospitals: a single-center study. Environ Sci Pollut Res Int. 2018;25(6):5459\u201364.", "ArticleIdList": ["29214477"]}, {"Citation": "Thabit AG, Hassan MA, Agban MN, Makhlouf NA, Khalil NK, Hassan HM, et al. Prevalence of occult HBV infection among chronic hepatitis C patients in upper Egypt. Environ Sci Pollut Res Int. 2017;24(1):131\u201342.", "ArticleIdList": ["29120585"]}, {"Citation": "El-Maksoud MA, Habeeb MR, Ghazy HF, Nomir MM, Elalfy H, Abed S, et al. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2019;31(6):716\u201322.", "ArticleIdList": ["30870221"]}, {"Citation": "Serwah MA, Omar SA, Khedr MS, Abdel-Hamid A. Occurrence and clinical characteristics of occult hepatitis C virus infection in hemodialysis units at Ismailia, Egypt. Eur J Gastroenterol Hepatol. 2021;33:1009\u201314.", "ArticleIdList": ["33731578"]}, {"Citation": "Selim HS, Abou-Donia HA, Taha HA, El Azab GI, Bakry AF. Role of occult hepatitis B virus in chronic hepatitis C patients with flare of liver enzymes. Eur J Intern Med. 2011;22(2):187\u201390.", "ArticleIdList": ["21402251"]}, {"Citation": "Mbangiwa T, Kasvosve I, Anderson M, Thami PK, Choga WT, Needleman A, et al. Chronic and occult Hepatitis B virus infection in pregnant women in Botswana. Genes (Basel) 2018;9(5)", "ArticleIdList": ["PMC5977199", "29772814"]}, {"Citation": "Abu El Makarem MA, Abdel Hamid M, Abdel Aleem A, Ali A, Shatat M, Sayed D, et al. Prevalence of occult hepatitis B virus infection in hemodialysis patients from egypt with or without hepatitis C virus infection. Hepat Mon. 2012;12(4):253\u20138.", "ArticleIdList": ["PMC3360934", "22690232"]}, {"Citation": "Youssef SS, Nasr AS, El Zanaty T, El Rawi RS, Mattar MM. Prevalence of occult hepatitis C virus in egyptian patients with chronic lymphoproliferative disorders. Hepat Res Treat. 2012;2012:429784.", "ArticleIdList": ["PMC3530786", "23304473"]}, {"Citation": "Elrashidy H, El-Didamony G, Elbahrawy A, Hashim A, Alashker A, Morsy MH, et al. Absence of occult hepatitis B virus infection in sera of diabetic children and adolescents following hepatitis B vaccination. Hum Vaccin Immunother. 2014;10(8):2336\u201341.", "ArticleIdList": ["PMC4896756", "25424940"]}, {"Citation": "Zaghloul H, El-Sherbiny W. Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells. Immunol Invest. 2010;39(3):284\u201391.", "ArticleIdList": ["20380524"]}, {"Citation": "Beykaso G, Mulu A, Giday M, Berhe N, Selamu M, Hailu D, et al. Occult Hepatitis B Virus Infection and Its Risks of Cryptic Transmission in Southern Ethiopia. Infect Drug Resist. 2022;15:619\u201330.", "ArticleIdList": ["PMC8886027", "35241914"]}, {"Citation": "Mekky MA, Sayed HI, Abdelmalek MO, Saleh MA, Osman OA, Osman HA, et al. Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a multi-center study. Infect Drug Resist. 2019;12:273\u20139.", "ArticleIdList": ["PMC6348965", "30774394"]}, {"Citation": "Foaud H, Maklad S, Mahmoud F, El-Karaksy H. Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis. Infection. 2015;43(3):307\u201314.", "ArticleIdList": ["25665956"]}, {"Citation": "Yousif MM, Elsadek Fakhr A, Morad EA, Kelani H, Hamed EF, Elsadek HM, et al. Prevalence of occult hepatitis C virus infection in patients who achieved sustained virologic response to direct-acting antiviral agents. Infez Med. 2018;26(3):237\u201343.", "ArticleIdList": ["30246766"]}, {"Citation": "Abdelaziz H, et al. Molecular and serological characterization of occult hepatitis B among blood donors in Maputo, Mozambique. Int J Immunopathol Pharm. 2020;115:e200006", "ArticleIdList": ["PMC7523502", "32997000"]}, {"Citation": "Firnhaber C, Viana R, Reyneke A, Schultze D, Malope B, Maskew M, et al. Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa. Int J Infect Dis. 2009;13(4):488\u201392.", "ArticleIdList": ["PMC3016468", "19081280"]}, {"Citation": "Mudawi H, Hussein W, Mukhtar M, Yousif M, Nemeri O, Glebe D, et al. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients. Int J Infect Dis. 2014;29:65\u201370.", "ArticleIdList": ["25449238"]}, {"Citation": "Youssef A, Yano Y, El-Sayed Zaki M, Utsumi T, Hayashi Y. Characteristics of hepatitis viruses among Egyptian children with acute hepatitis. Int J Oncol. 2013;42(4):1459\u201365.", "ArticleIdList": ["23404231"]}, {"Citation": "Lotfi AA, Mohamed AE, Shalaby NA, Eissa DS, El-Dabaa E, Sallam AM, et al. Occult hepatitis C virus infection in patients with malignant lymphoproliferative disorders. Int J Immunopathol Pharmacol. 2020;34:2058738420961202.", "ArticleIdList": ["PMC7557643", "33045856"]}, {"Citation": "Firnhaber C, Chen CY, Evans D, Maskew M, Schulz D, Reyneke A, et al. Prevalence of hepatitis B virus (HBV) co-infection in HBV serologically-negative South African HIV patients and retrospective evaluation of the clinical course of mono-and co-infection. Int J Infect Dis. 2012;16(4):E268\u201372.", "ArticleIdList": ["22305987"]}, {"Citation": "Bajjou T, Elannaz H, Tagajdid M, Elghafouli H, Laraqui A, Abi R, et al. Occult hepatitis B virus infection in Moroccan HIV infected patients. Int J Res Med Sci. 2015 March;3(3):617. 2015 2017."}, {"Citation": "Youssef A, Yano Y, Utsumi T, abd El-alah EM, abd El-Hameed A, Serwah A, et al. Molecular epidemiological study of hepatitis viruses in Ismailia, Egypt. Intervirology. 2009;52(3):123\u201331.", "ArticleIdList": ["19468235"]}, {"Citation": "Hamers RL, Zaaijer HL, Wallis CL, Siwale M, Ive P, Botes ME, et al. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes. J Acquir Immune Defic Syndr. 2013;64(2):174\u201382.", "ArticleIdList": ["23892239"]}, {"Citation": "Mahgoub S, Candotti D, El Ekiaby M, Allain JP. Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan. J Clin Microbiol. 2011;49(1):298\u2013306.", "ArticleIdList": ["PMC3020474", "21048009"]}, {"Citation": "Abd Alla MDA, Elibiary SA, Wu GY, El-Awady MK. Occult HCV Infection (OCI) diagnosis in cirrhotic and non-cirrhotic na\u00efve patients by intra-PBMC nested viral RNA PCR. J Clin Transl Hepatol. 2017;5(4):319\u201326.", "ArticleIdList": ["PMC5719189", "29226098"]}, {"Citation": "Amponsah-Dacosta E, Lebelo RL, Rakgole JN, Selabe SG, Gededzha MP, Mayaphi SH, et al. Hepatitis B virus infection in post-vaccination South Africa: occult HBV infection and circulating surface gene variants. J Clin Virol. 2015;63:12\u20137.", "ArticleIdList": ["PMC4560343", "25600597"]}, {"Citation": "Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol. 2006;35(1):14\u201320.", "ArticleIdList": ["15916918"]}, {"Citation": "Abd El Kader Mahmoud O, Abd El Rahim Ghazal A, El Sayed Metwally D, Elnour AM, Yousif GE. Detection of occult hepatitis B virus infection among blood donors in Sudan. J Egypt Public Health Assoc. 2013;88(1):14\u20138.", "ArticleIdList": ["23528527"]}, {"Citation": "El-Ghitany EM, Farghaly AG, Hashish MH. Occult hepatitis B virus infection among hepatitis C virus seropositive and seronegative blood donors in Alexandria, Egypt. J Egypt Public Health Assoc. 2013;88(1):8\u201313.", "ArticleIdList": ["23528526"]}, {"Citation": "El-Sherif A, Abou-Shady M, Abou-Zeid H, Elwassief A, Elbahrawy A, Ueda Y, et al. Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients. J Gastroenterol. 2009;44(4):359\u201364.", "ArticleIdList": ["19271112"]}, {"Citation": "Kew MC, Welschinger R, Viana R. Occult hepatitis B virus infection in Southern African blacks with hepatocellular carcinoma. J Gastroenterol Hepatol. 2008;23(9):1426\u201330.", "ArticleIdList": ["18853999"]}, {"Citation": "Shaker O, Ahmed A, Abdel Satar I, El Ahl H, Shousha W, Doss W. Occult hepatitis B in Egyptian thalassemic children. J Infect Dev Ctries. 2012;6(4):340\u20136.", "ArticleIdList": ["22505444"]}, {"Citation": "Ndow G, et al. Prevalence and clinical significance of occult hepatitis B infection in The Gambia, West Africa. J Infect Dis. 2021", "ArticleIdList": ["PMC9470103", "34160616"]}, {"Citation": "Helaly GF, El Ghazzawi EF, Shawky SM, Farag FM. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt. J Infect Public Health. 2015;8(6):562\u20139.", "ArticleIdList": ["26026236"]}, {"Citation": "Omar HH, Taha SA, Hassan WH, Omar HH. Impact of schistosomiasis on increase incidence of occult hepatitis B in chronic hepatitis C patients in Egypt. J Infect Public Health. 2017;10(6):761\u20135.", "ArticleIdList": ["28196636"]}, {"Citation": "Hoffmann CJ, Mashabela F, Cohn S, Hoffmann JD, Lala S, Martinson NA, et al. Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa. J Int AIDS Soc. 2014;17(1):18871.", "ArticleIdList": ["PMC4032505", "24855985"]}, {"Citation": "Abdelrahim SS, Khairy R, Esmail MA, Ragab M, Abdel-Hamid M, Abdelwahab SF. Occult hepatitis C virus infection among Egyptian hemodialysis patients. J Med Virol. 2016;88(8):1388\u201393.", "ArticleIdList": ["26743014"]}, {"Citation": "Apica BS, Seremba E, Rule J, Yuan HJ, Lee WM. High prevalence of occult hepatitis B infection in an African urban population. J Med Virol. 2016;88(4):674\u201380.", "ArticleIdList": ["26334654"]}, {"Citation": "Barth RE, Huijgen Q, Tempelman HA, Mudrikova T, Wensing AM, Hoepelman AI. Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa. J Med Virol. 2011;83(6):929\u201334.", "ArticleIdList": ["21503902"]}, {"Citation": "Compston LI, Li C, Sarkodie F, Owusu-Ofori S, Opare-Sem O, Allain JP. Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa. J Med Virol. 2009;81(11):1860\u20138.", "ArticleIdList": ["19774687"]}, {"Citation": "El Shazly Y, Hemida K, Rafik M, Al Swaff R, Ali-Eldin ZA, GadAllah S. Detection of occult hepatitis C virus among healthy spouses of patients with HCV infection. J Med Virol. 2015;87(3):424\u20137.", "ArticleIdList": ["25185940"]}, {"Citation": "Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele MJ. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. J Med Virol. 2009;81(3):406\u201312.", "ArticleIdList": ["19152393"]}, {"Citation": "Meschi S, Schepisi MS, Nicastri E, Bevilacqua N, Castilletti C, Sciarrone MR, et al. The prevalence of antibodies to human herpesvirus 8 and hepatitis B virus in patients in two hospitals in Tanzania. J Med Virol. 2010;82(9):1569\u201375.", "ArticleIdList": ["20648611"]}, {"Citation": "Musyoki AM, Msibi TL, Motswaledi MH, Selabe SG, Monokoane TS, Mphahlele MJ. Active co-infection with HBV and/or HCV in South African HIV positive patients due for cancer therapy. J Med Virol. 2015;87(2):213\u201321.", "ArticleIdList": ["25156907"]}, {"Citation": "Powell EA, Gededzha MP, Rentz M, Rakgole NJ, Selabe SG, Seleise TA, et al. Mutations associated with occult hepatitis B in HIV-positive South Africans. J Med Virol. 2015;87(3):388\u2013400.", "ArticleIdList": ["PMC4562318", "25164924"]}, {"Citation": "El-Sayed MH, Said Z, Abo-Elmagd EK, Ebeid F, Salama II. High risk of HBV infection among vaccinated polytransfused children with malignancy. J Pedia Hematol Oncol. 2021;43(1):e45\u201350.", "ArticleIdList": ["32769568"]}, {"Citation": "Opaleye OO, Oluremi AS, Atiba AB, Adewumi MO, Mabayoje OV, Donbraye E, et al. Occult Hepatitis B virus infection among HIV positive patients in Nigeria. J Trop Med. 2014;2014:796121.", "ArticleIdList": ["PMC4020157", "24868208"]}, {"Citation": "Raouf HE, Yassin AS, Megahed SA, Ashour MS, Mansour TM. Seroprevalence of occult hepatitis B among Egyptian paediatric hepatitis C cancer patients. J Viral Hepat. 2015;22(2):103\u201311.", "ArticleIdList": ["24754376"]}, {"Citation": "Chasela CS, Kourtis AP, Wall P, Drobeniuc J, King CC, Thai H, et al. Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants. J Hepatol. 2014;60(3):508\u201314.", "ArticleIdList": ["PMC4411040", "24211737"]}, {"Citation": "Kitab B, Ezzikouri S, Alaoui R, Nadir S, Badre W, Trepo C, et al. Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma. Liver Int. 2014;34(6):e144\u201350.", "ArticleIdList": ["24502524"]}, {"Citation": "Said ZN, El-Sayed MH, El-Bishbishi IA, El-Fouhil DF, Abdel-Rheem SE, El-Abedin MZ, et al. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies. Liver Int. 2009;29(4):518\u201324.", "ArticleIdList": ["19192168"]}, {"Citation": "Mhalla S, Hammoud R, Frih A, Kadri Y, El Argoubi A, Elmay M, et al. Prevalence and risk factors of hepatitis B and C among hemodialysis patients in Tunisia. Med Mal Infect. 2018;48(3):175\u20139.", "ArticleIdList": ["29249466"]}, {"Citation": "Diarra B, Yonli AT, Sorgho PA, Compaore TR, Ouattara AK, Zongo WA, et al. Occult Hepatitis B Virus Infection and Associated Genotypes among HBsAg-negative Subjects in Burkina Faso. Mediterr J Hematol Infect Dis. 2018;10(1):e2018007.", "ArticleIdList": ["PMC5760064", "29326804"]}, {"Citation": "Akinbami A, Badiru M, Uche E, Onyekwere C, Ismail K, Olowoselu O, et al. The Prevalence of Occult Hepatitis B Infection among Blood Donors in Lagos, Nigeria. Niger Med J. 2019;60(1):22\u20136.", "ArticleIdList": ["PMC6677000", "31413431"]}, {"Citation": "Otegbayo JA, et al. Profile of Hepatitis B and Hepatitis C Markers in Asymptomatic Chronic HBV Infection in an Endemic Population. Niger J Gastroenterol Hepatol. 2009;1(2)"}, {"Citation": "Ryan K, Anderson M, Gyurova I, Ambroggio L, Moyo S, Sebunya T, et al. High Rates of Occult Hepatitis B Virus Infection in HIV-positive individuals initiating antiretroviral therapy in Botswana. Open Forum Infect Dis. 2017;4(4):ofx195.", "ArticleIdList": ["PMC5641381", "29062862"]}, {"Citation": "Kengne M, Medja Y, Tedom, Nwobegahay JM. Residual risk for transfusion-transmitted hepatitis B virus infection due to occult hepatitis B virus infection in donors living in Yaound\u00e9, Cameroon. Pan Afr Med J. 2021;39:175.", "ArticleIdList": ["PMC8449568", "34584601"]}, {"Citation": "Peliganga LB, Mello VM, de Sousa P, Horta M, Soares \u00c1D, Nunes J, et al. Transfusion transmissible infections in blood donors in the Province of Bi\u00e9, Angola, during a 15-Year follow-up, imply the need for pathogen reduction technologies. Pathogens. 2021;10(12)", "ArticleIdList": ["PMC8705259", "34959588"]}, {"Citation": "Aluora PO. Seroprevalence and genotypic characterization of HBV among low risk voluntary blood donors in Nairobi, Kenya. PLoS One. 2020;17(1):176.", "ArticleIdList": ["PMC7666503", "33187530"]}, {"Citation": "Bell TG, Makondo E, Martinson NA, Kramvis A. Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt-that is the question. PLoS One. 2012;7(10):e45750.", "ArticleIdList": ["PMC3462206", "23049685"]}, {"Citation": "Bivigou-Mboumba B, Amougou-Atsama M, Zoa-Assoumou S, M\u2019boyis Kamdem H, Nzengui-Nzengui GF, Ndojyi-Mbiguino A, et al. Hepatitis B infection among HIV infected individuals in Gabon: occult hepatitis B enhances HBV DNA prevalence. PLoS One. 2018;13(1):e0190592.", "ArticleIdList": ["PMC5760027", "29315352"]}, {"Citation": "Bivigou-Mboumba B, Fran\u00e7ois-Souqui\u00e8re S, Deleplancque L, Sica J, Mouinga-Ond\u00e9m\u00e9 A, Amougou-Atsama M, et al. Broad Range of Hepatitis B Virus (HBV) patterns, dual circulation of quasi-subgenotype A3 and HBV/E and heterogeneous HBV mutations in HIV-positive patients in Gabon. PLoS One. 2016;11(1):e0143869.", "ArticleIdList": ["PMC4713159", "26764909"]}, {"Citation": "Carimo AA, Gudo ES, Maueia C, Mabunda N, Chambal L, Vubil A, et al. First report of occult hepatitis B infection among ART na\u00efve HIV seropositive in-dividuals in Maputo, Mozambique. PLoS One. 2018;13(1):e0190775.", "ArticleIdList": ["PMC5761887", "29320552"]}, {"Citation": "Jepkemei KB, Ochwoto M, Swidinsky K, Day J, Gebrebrhan H, McKinnon LR, et al. Characterization of occult hepatitis B in high-risk populations in Kenya. PLoS One. 2020;15(5):e0233727.", "ArticleIdList": ["PMC7255601", "32463824"]}, {"Citation": "Oluyinka OO, Tong HV, Bui Tien S, Fagbami AH, Adekanle O, Ojurongbe O, et al. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks. PLoS One. 2015;10(7):e0131912.", "ArticleIdList": ["PMC4492924", "26148052"]}, {"Citation": "Patel NH, Meier-Stephenson V, Genetu M, Damtie D, Abate E, Alemu S, et al. Prevalence and genetic variability of occult hepatitis B virus in a human im-munodeficiency virus positive patient cohort in Gondar, Ethiopia. PLoS One. 2020;15(11):e0242577.", "ArticleIdList": ["PMC7704059", "33211768"]}, {"Citation": "Salyani A, Shah J, Adam R, Otieno G, Mbugua E, Shah R. Occult hepatitis B virus infection in a Kenyan cohort of HIV infected anti-retroviral therapy naive adults. PloS One. 2021;16(1):e0244947. 0244947.", "ArticleIdList": ["PMC7787452", "33406137"]}, {"Citation": "Mandour M, Nemr N, Shehata A, Kishk R, Badran D, Hawass N. Occult HBV infection status among chronic hepatitis C and hemodialysis patients in Northeastern Egypt: regional and national overview. Rev Soc Bras Med Trop. 2015;48(3):258\u201364.", "ArticleIdList": ["26108002"]}, {"Citation": "Ayuk J, Mphahlele J, Bessong P. Hepatitis B virus in HIV-infected patients in northeastern South Africa: prevalence, exposure, protection and response to HAART. S Afr Med J. 2013;103(5):330\u20133.", "ArticleIdList": ["23971125"]}, {"Citation": "Mayaphi SH, Roussow TM, Masemola DP, Olorunju SA, Mphahlele MJ, Martin DJ. HBV/HIV co-infection: the dynamics of HBV in South African patients with AIDS. S Afr Med J. 2012;102(3 Pt 1):157\u201362.", "ArticleIdList": ["22380911"]}, {"Citation": "Alduraywish A, Ragheb M, Taher I, Louis N, Aldossari K, Kishk R. Prevalence, risk factors and impact of occult HCV infection on liver morbidity among haemo-dialysis patients: hospital-based cross-sectional study. Scand J Gastroenterol. 2020;55(8):963\u20139.", "ArticleIdList": ["32649843"]}, {"Citation": "Ayana DA, Mulu A, Mihret A, Seyoum B, Aseffa A, Howe R. Occult Hepatitis B virus infection among HIV negative and positive isolated anti-HBc individuals in eastern Ethiopia. Sci Rep. 2020;10(1):22182.", "ArticleIdList": ["PMC7747707", "33335238"]}, {"Citation": "de Mendoza C, Bautista JM, P\u00e9rez-Benavente S, Kwawu R, Fobil J, Soriano V, et al. Screening for retroviruses and hepatitis viruses using dried blood spots reveals a high prevalence of occult hepatitis B in Ghana. Ther Adv Infect Dis. 2019;6:2049936119851464.", "ArticleIdList": ["PMC6535694", "31205689"]}, {"Citation": "El-Zayadi AR, Ibrahim EH, Badran HM, Saeid A, Moneib NA, Shemis MA, et al. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission. Transfus Med. 2008;18(1):55\u201361.", "ArticleIdList": ["18279193"]}, {"Citation": "Busch M, et al. Seronegative and occult hepatitis C virus infections in patients with hematological disorders. Transfusion. 2017;162(1):63\u20139.", "ArticleIdList": ["27665588"]}, {"Citation": "Sondlane TH, Mawela L, Razwiedani LL, Selabe SG, Lebelo RL, Rakgole JN, et al. High prevalence of active and occult hepatitis B virus infections in healthcare workers from two provinces of South Africa. Vaccine. 2016;34(33):3835\u20139.", "ArticleIdList": ["27265453"]}, {"Citation": "Belyhun Y, Liebert UG, Maier M. Molecular epidemiology of hepatitis B virus among HIV co-infected and mono-infected cohorts in Northwest Ethiopia. Virol J. 2022;19(1):53.", "ArticleIdList": ["PMC8944073", "35331278"]}, {"Citation": "Emara MH, El-Gammal NE, Mohamed LA, Bahgat MM. Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy. Virol J. 2010;7:324.", "ArticleIdList": ["PMC2998483", "21083926"]}, {"Citation": "Hassan ZK, Hafez MM, Mansor TM, Zekri AR. Occult HBV infection among Egyptian hepatocellular carcinoma patients. Virol J. 2011;8:90.", "ArticleIdList": ["PMC3058093", "21371325"]}, {"Citation": "Kishk R, Nemr N, Elkady A, Mandour M, Aboelmagd M, Ramsis N, et al. Hepatitis B surface gene variants isolated from blood donors with overt and occult HBV infection in north eastern Egypt. Virol J. 2015;12:153.", "ArticleIdList": ["PMC4588243", "26420301"]}, {"Citation": "Olotu AA, Oyelese AO, Salawu L, Audu RA, Okwuraiwe AP, Aboderin AO. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virol J. 2016;13:76.", "ArticleIdList": ["PMC4859058", "27150469"]}, {"Citation": "Burnett RJ, et al. Molecular detection of occult Hepatitis B virus in plasma and urine of renal transplant patients in Khartoum state Sudan. Viruses. 2020;97:126\u201330.", "ArticleIdList": ["32497807"]}, {"Citation": "van Drimmelen H, et al. Surveillance and impact of occult hepatitis B virus, SEN virus, and torque teno virus in Egyptian hemodialysis patients with chronic hepatitis C virus infection. Vox Sang. 2020;92:13\u20138.", "ArticleIdList": ["31863879"]}, {"Citation": "Attia KA, Eholi\u00e9 S, Messou E, Danel C, Polneau S, Chenal H, et al. Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients. World J Hepatol. 2012;4(7):218\u201323.", "ArticleIdList": ["PMC3409356", "22855697"]}, {"Citation": "Elkady A, Iijima S, Aboulfotuh S, Mostafa Ali E, Sayed D, Abdel-Aziz NM, et al. Characteristics of escape mutations from occult hepatitis B virus infected patients with hematological malignancies in South Egypt. World J Hepatol. 2017;9(9):477\u201386.", "ArticleIdList": ["PMC5368625", "28396718"]}, {"Citation": "Said ZN, Sayed MH, Salama II, Aboel-Magd EK, Mahmoud MH, Setouhy ME, et al. Occult hepatitis B virus infection among Egyptian blood donors. World J Hepatol. 2013;5(2):64\u201373.", "ArticleIdList": ["PMC3642725", "23646231"]}, {"Citation": "Kouyoumjian SP, Chemaitelly H, Abu-Raddad LJ. Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and metaregressions. Sci Rep. 2018;8(1):1661.", "ArticleIdList": ["PMC5785953", "29374178"]}, {"Citation": "Karoney MJ, Siika AM. Hepatitis C virus (HCV) infection in Africa: a review. Pan Afr Med J. 2013;14:44.", "ArticleIdList": ["PMC3612901", "23560127"]}, {"Citation": "D\u2019Ambrosio R, Degasperi E, Colombo M, Aghemo A. Direct-acting antivirals: the endgame for hepatitis C? Curr Opin Virol. 2017;24:31\u20137.", "ArticleIdList": ["28419938"]}, {"Citation": "Kenfack-Momo R, Kenmoe S, Takuissu GR, Ebogo-Belobo JT, Kengne-Nd\u00e9 C, Mbaga DS, et al. Epidemiology of hepatitis B virus and/or hepatitis C virus infections among people living with human immunodeficiency virus in Africa: a systematic review and meta-analysis. PLoS One. 2022;17(5):e0269250.", "ArticleIdList": ["PMC9154112", "35639675"]}, {"Citation": "Zampino R, Boemio A, Sagnelli C, Alessio L, Adinolfi LE, Sagnelli E, et al. Hepatitis B virus burden in developing countries. World J Gastroenterol. 2015;21(42):11941\u201353.", "ArticleIdList": ["PMC4641116", "26576083"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "9", "Day": "6"}, {"Year": "2022", "Month": "11", "Day": "4"}, {"Year": "2022", "Month": "11", "Day": "8"}, {"Year": "2022", "Month": "11", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "17", "Hour": "18", "Minute": "26"}, {"Year": "2022", "Month": "12", "Day": "2"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36395668", "EMS157310", "PMC7613883", "10.1016/j.jiph.2022.11.008", "S1876-0341(22)00303-3"]}}], "PubmedBookArticle": []}